Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Re: Shares Outstanding - reduced from 2009 to 2013

Oct 09, 2013 10:05AM
1
Oct 09, 2013 10:16AM

"How did we go from 369 Million to 405 Million shares outstanding?"

What are you talking about???
The OS was reduced over the last five years.

From the 10K 2013:
"On August 16, 2013, 405,247,405 shares of common stock, par value $0.00001 per share were outstanding."

From the 10K 2012:
"On August 15, 2012, 405,575,249 shares of common stock, par value $0.00001 per share were outstanding."

From the 10K 2011:
"On August 12, 2011, 406,972,710 shares of common stock, par value $0.00001 per share were outstanding."

From the 10K 2010:
"On July 31, 2010, 408,552,671 shares of common stock, par value $0.00001 per share were outstanding."

From the 10K 2009:
"On July 31, 2009, 410,304,054 shares of common stock, par value $.00001 per share were outstanding."


3
Oct 09, 2013 10:19AM

Oct 09, 2013 10:19AM
1
Oct 09, 2013 10:22AM
1
Oct 09, 2013 11:04AM
4
Oct 09, 2013 11:31AM
1
Oct 09, 2013 11:34AM

Oct 09, 2013 11:50AM
1
Oct 09, 2013 12:16PM

Oct 09, 2013 08:33PM
Share
New Message
Please login to post a reply